Investment
Features
FeesSafety
Academy
More
Pluang+

Revolut and Nubank face tough challenges expanding US banking despite high valuations.

Market News
23 Sep 2026
PYMNTS
View Source
Neutral
Revolut and Nubank face tough challenges expanding US banking despite high valuations.

Revolut and Nubank, the world's two most-valued digital banks, have received conditional approval to operate in the US and are aiming to expand in this highly competitive market. Nubank has already launched its US offering, while Revolut plans an IPO in 2028 and must justify its $115 billion valuation. Despite their success in Europe and Latin America, both face challenges due to complex US regulations and strong local competitors. Their ability to attract Gen Z consumers, who prefer integrated digital financial services, will be crucial for growth in the US market.

Revolut and Nubank's US banking expansion comes amid a Financials sector where 31 of 84 US stocks rose and 52 fell on Pluang as of Sep 23, 2026 21:51 WIB. Among notable movers, Affirm Holdings Inc (AFRM) traded at USD 67.67 with a 1-day decline of 5.71%, Lemonade Inc (LMND) at USD 45.37 down 4.86% but showing strong buy interest with 97% of Pluang orders, and Gemini Space Station Inc (GEMI) at USD 5.69 down 4.37% with a majority sell order activity of 57%. Typical hold times ranged from 12 to 26 days across these stocks.

More News

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

Jefferies analysts set a new price target of $435 for General Electric Aerospace, implying a 35% upside from its current price of around $321. GE Aerospace's strong position is supported by a $170 billion commercial services backlog and 80,000 aircra...

Analyst Insights
Bullish
28 minutes ago
BNP Paribas cuts PepsiCo price target to $161, citing demand challenges but keeps Outperform rating.

BNP Paribas cuts PepsiCo price target to $161, citing demand challenges but keeps Outperform rating.

BNP Paribas lowered its price target for PepsiCo from $183 to $161 on September 23, 2026, due to ongoing demand challenges in North America. Despite the cut, the firm maintained an Outperform rating, indicating confidence in the stock's potential. Th...

Analyst Insights
Bearish
1 hour ago
Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex Therapeutics saw its price target raised from $70 to $88 by Leerink Partners following successful Phase III trial results for its drug barzolvolimab treating chronic spontaneous urticaria (CSU). The trials met all primary endpoints, showing l...

Analyst Insights
Bullish
2 hours ago
Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper, a major copper producer, shows stock volatility between $16.88 and $40.83 over the past year. Analyst firm CIBC maintained a "Neutral" rating but increased the price target to C$56.00, reflecting optimism about the company's long-term gro...

Analyst Insights
Bullish
2 hours ago
Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas Corporation posted robust first-quarter results, surpassing analyst expectations with earnings per share of $1.39 and revenue of $3.01 billion, a 10.9% increase year-over-year. The company's organic revenue growth was 8.9%, reflecting solid bu...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App